[Multiparameter analysis of uterine cancer cells using flow-cytometry-computer]. 1982

I Nishiya, and T Izutsu, and S Nunokawa, and T Hirama

In recent progress, Laser-based flow cytometric technique makes it possible to do quantitative determination of nuclear DNA-RNA content and proteins on monodisperse cell population simultaneously. Gynecologic cytology specimens that derived from the cervix and the endometrium were stained with a combination of propidium iodide for nuclear DNA-RNA and fluorescein isothiocyanate for protein in cells, then analyzed using a flow cytometry system with computer. These results included assessment of the presence or absence of malignant cells. They also demonstrated the dispersion contour of the normal squamous cell population, and inflammatory responding cell population. Measurements of clinical specimens were resulted with a 9.6% false negative rate and a 27.0% false positive rate (80.6% in accuracy rate) by comparison with routine visual cytologic evaluation of the same samples.

UI MeSH Term Description Entries
D007834 Lasers An optical source that emits photons in a coherent beam. Light Amplification by Stimulated Emission of Radiation (LASER) is brought about using devices that transform light of varying frequencies into a single intense, nearly nondivergent beam of monochromatic radiation. Lasers operate in the infrared, visible, ultraviolet, or X-ray regions of the spectrum. Masers,Continuous Wave Lasers,Pulsed Lasers,Q-Switched Lasers,Continuous Wave Laser,Laser,Laser, Continuous Wave,Laser, Pulsed,Laser, Q-Switched,Lasers, Continuous Wave,Lasers, Pulsed,Lasers, Q-Switched,Maser,Pulsed Laser,Q Switched Lasers,Q-Switched Laser
D009363 Neoplasm Proteins Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm. Proteins, Neoplasm
D003201 Computers Programmable electronic devices designed to accept data, perform prescribed mathematical and logical operations at high speed, and display the results of these operations. Calculators, Programmable,Computer Hardware,Computers, Digital,Hardware, Computer,Calculator, Programmable,Computer,Computer, Digital,Digital Computer,Digital Computers,Programmable Calculator,Programmable Calculators
D004273 DNA, Neoplasm DNA present in neoplastic tissue. Neoplasm DNA
D005260 Female Females
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D005456 Fluorescent Dyes Chemicals that emit light after excitation by light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags. Flourescent Agent,Fluorescent Dye,Fluorescent Probe,Fluorescent Probes,Fluorochrome,Fluorochromes,Fluorogenic Substrates,Fluorescence Agents,Fluorescent Agents,Fluorogenic Substrate,Agents, Fluorescence,Agents, Fluorescent,Dyes, Fluorescent,Probes, Fluorescent,Substrates, Fluorogenic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012334 RNA, Neoplasm RNA present in neoplastic tissue. Neoplasm RNA
D014594 Uterine Neoplasms Tumors or cancer of the UTERUS. Cancer of Uterus,Uterine Cancer,Cancer of the Uterus,Neoplasms, Uterine,Neoplasms, Uterus,Uterus Cancer,Uterus Neoplasms,Cancer, Uterine,Cancer, Uterus,Cancers, Uterine,Cancers, Uterus,Neoplasm, Uterine,Neoplasm, Uterus,Uterine Cancers,Uterine Neoplasm,Uterus Cancers,Uterus Neoplasm

Related Publications

I Nishiya, and T Izutsu, and S Nunokawa, and T Hirama
January 1985, Survey and synthesis of pathology research,
I Nishiya, and T Izutsu, and S Nunokawa, and T Hirama
January 1993, Verhandlungen der Deutschen Gesellschaft fur Pathologie,
I Nishiya, and T Izutsu, and S Nunokawa, and T Hirama
January 2000, Journal of immunoassay,
I Nishiya, and T Izutsu, and S Nunokawa, and T Hirama
January 1990, Methods in cell biology,
I Nishiya, and T Izutsu, and S Nunokawa, and T Hirama
January 1994, Methods in cell biology,
I Nishiya, and T Izutsu, and S Nunokawa, and T Hirama
March 1987, Cytometry,
I Nishiya, and T Izutsu, and S Nunokawa, and T Hirama
October 1986, Presse medicale (Paris, France : 1983),
I Nishiya, and T Izutsu, and S Nunokawa, and T Hirama
October 2013, Current protocols in cytometry,
I Nishiya, and T Izutsu, and S Nunokawa, and T Hirama
January 2018, Methods in molecular biology (Clifton, N.J.),
I Nishiya, and T Izutsu, and S Nunokawa, and T Hirama
January 1985, Survey and synthesis of pathology research,
Copied contents to your clipboard!